News Valeant constipation drug approved in US FDA panel also recommends Valeant's psoriasis medicine.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
